Completed PHASE1 INTERVENTIONAL 2-arm NCT04200235

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

Study on Pharmacokinetics and Clinical Efficacy of Dexmedetomidine Hydrochloride Nasal Spray for Preoperative Sedation in Children

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Conditions Preoperative Sedation

Interventions Dexmedetomidine hydrochloride nasal spray Dexmedetomidine hydrochloride nasal spray blank preparation.

Updated 7 times since 2020 Last updated: Sep 7, 2020 Started: Jan 6, 2020 Primary completion: Aug 6, 2020 Completion: Aug 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Preoperative Sedation, this trial is completed. The trial is conducted by Jiangsu HengRui Medicine Co., Ltd. and has accumulated 7 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Oct 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jun 2020 — Oct 2020 [monthly]

Recruiting PHASE1

▶ Show 2 earlier versions

Feb 2020 — Jun 2020 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jan 2020 — Feb 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu HengRui Medicine Co., Ltd.

Data source: Jiangsu HengRui Medicine Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China